COMMUNIQUÉS West-GlobeNewswire

Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806
25/03/2019
– CG-806 highly potent, oral, non-covalent pan-FLT3/pan-BTK inhibitor being developed for the treatment of CLL and other B-cell malignancies and for AML – – Phase 1 trial in relapsed or refractory CLL and B cell [...]
Notice of Results
25/03/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2019 Oxford, UK, and Cambridge, MA, US, 25 March 2019 [...]
Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
25/03/2019
--On Track to Complete its Three Phase 3 Clinical Trials in 2019 -- --Received Qualified Infectious Disease Product Designation in Four Additional Indications-- --Fast Track Designation received from the FDA in seven [...]
MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results
25/03/2019
Met Primary and All Secondary Endpoints in its Pivotal Phase 3 Study (DETECT) in NexoBrid ® for Eschar Removal of Severe Thermal Burns Awarded Additional BARDA Contract Valued up to $43 Million for the Development of [...]
Arvinas Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of PROTAC™ Protein Degrader, ARV-110
25/03/2019
Study to Evaluate Safety and Tolerability of Androgen Receptor (AR)-targeted PROTAC™ Protein Degrader in Patients with Metastatic Castration-Resistant Prostate Cancer NEW HAVEN, Conn., March 25, 2019 (GLOBE NEWSWIRE [...]
Canopy Rivers Portfolio Company Licensed by Health Canada, Triggering Long-Term Cash Flow Stream
25/03/2019
TORONTO, March 25, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (“ Canopy Rivers ” or the “ Company ”) (TSXV: RIV) congratulates Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“ Canopy Growth ”) and its portfolio [...]
XORTX Shares Findings of New Diabetes Study Supporting Uric Acid as an Independent Risk Factor
25/03/2019
● An Opportunity to Expand XORTX’s Pipeline under Existing Patents ● CALGARY, Alberta, March 25, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a [...]
Publication Identifies Cyclin E as Key Resistance Pathway to Breast Cancer Treated by CDK4/6 Inhibitors and Thereby Amenable to Treatment by CYC065 CDK2/9 Inhibitor
25/03/2019
-- PALOMA-3 study gene expression profiling shows that CDK2 is a key kinase bypass mechanism after treatment with palbociclib plus hormone therapy -- -- Cyclin E is proposed as the first predictive biomarker of [...]
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
25/03/2019
MALVERN, Pa., March 25, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care settings, today [...]
Exactus Acquires Hemp Healthy® Online Consumer and Healthcare Practitioner Brand with Full Traceability
25/03/2019
Exactus Inc., to Introduce New CBD Products via www.buyhempcbd.com and Establish Platform as an Industry Leading Resource for Professionals and Consumers DELRAY BEACH, Fla., March 25, 2019 (GLOBE NEWSWIRE) -- Exactus [...]
Nexstim Plc: Resolutions of the annual general meeting of shareholders, 25 March 2019
25/03/2019
Company announcement, Helsinki, 25 March 2019, at 12 PM Nexstim Plc: Resolutions of the annual general meeting of shareholders, 25 March 2019 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted [...]
INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Drug Dependence Annual Scientific Meeting
25/03/2019
PHOENIX, March 25, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
Mesoblast Licensee Files for Marketing Approval to Treat Epidermolysis Bullosa
25/03/2019
NEW YORK and MELBOURNE, Australia, March 25, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced its licensee in Japan, JCR Pharmaceuticals Co. Ltd., has filed to extend marketing approval [...]
Arrayit Corporation Appoints Apple Enterprise Healthcare Partner to Accelerate FY2019 Revenues and Earnings Growth
25/03/2019
Sunnyvale, March 25, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, is working closely with an Apple enterprise healthcare partner to increase revenues and [...]
TLC to Present High-Scoring Scientific Abstracts on Acute Pain through Moderated Sessions at ASRA Spring 2019
25/03/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 25, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of [...]
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Proposed Business Transaction With Immunic AG and All the Related Proposals
25/03/2019
SAN DIEGO, March 25, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (VTL) announced today that Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) have both recommended that Vital [...]
Aino Health AB (publ): Aino Health hosts a seminar on value-based leadership
25/03/2019
25 th March, 2019 Aino Health is hosting the INSEAD seminar "Value-Based Leadership and Business as a Force for Good" on 27 March. The seminar will explore "Fair Process Leadership," an approach to leadership that [...]
Finns choose a domestic nicotine-free product as their preferred smoking intervention method
25/03/2019
Biohit Oyj and Sanoma Media invited 40 volunteers to try and quit smoking by using Acetium® lozenge and asked for feedback on their experience of using this alternative method. They received encouraging and positive [...]
Philips expands its radiology solutions offering with advanced teleradiology services
25/03/2019
March 25, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is expanding its radiology solutions portfolio with innovative [...]

Pages